TheraRadar
Data updated: May 26, 2026

OXICONAZOLE NITRATE

Infectious Disease Approved 2016-03-07

OXICONAZOLE NITRATE is indicated for the treatment of Tinea Pedis; Tinea Cruris; Tinea Corporis; Tinea Versicolor.

Source: FDA Label • SUN PHARMA CANADA
1
Indication
--
Phase 3 Trials
10
Years on Market

Details

Status
Prescription
First Approved
2016-03-07
Routes
TOPICAL
Dosage Forms
CREAM

Companies

Active Ingredient: OXICONAZOLE NITRATE

OXICONAZOLE NITRATE Approval History

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2016 to 2016
Mar 2016 ORIGINAL
Update

What OXICONAZOLE NITRATE Treats

4 indications

OXICONAZOLE NITRATE is approved for 4 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Tinea Pedis
  • Tinea Cruris
  • Tinea Corporis
  • Tinea Versicolor
Source: FDA Label

OXICONAZOLE NITRATE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to OXICONAZOLE NITRATE

3 of 19

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CLOTRIMAZOLE
CLOTRIMAZOLE
4 shared
Hikma
Shared indications:
Tinea VersicolorTinea PedisTinea Cruris +1 more
EXELDERM
SULCONAZOLE NITRATE
4 shared
JOURNEY
Shared indications:
CLOTIC
CLOTRIMAZOLE
3 shared
CARWIN PHARM ASSOC
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

OXICONAZOLE NITRATE FDA Label Details

Indications & Usage

FDA Label (PDF)

OXICONAZOLE NITRATE is indicated for the treatment of Tinea Pedis; Tinea Cruris; Tinea Corporis; Tinea Versicolor.

Looking for the branded version?

OXISTAT

Full clinical data, patents, trials, and competitive landscape for oxiconazole nitrate.

See OXISTAT

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.